Fifth Third Bancorp
ARKG icon

Fifth Third Bancorp’s ARK Genomic Revolution ETF ARKG Stock Holding History

Fifth Third Bancorp’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Buy
3,794
+1,695
+81% +$54K ﹤0.01% 2727
2026
Q1 		$55.5K Buy
+2,099
New +$61.5K ﹤0.01% 3152
2022
Q1 		– Sell
-125
Closed -$8K – 2664
2021
Q4 		$8K Sell
125
-175
-58% -$12.1K ﹤0.01% 2158
2021
Q3 		$22K Buy
+300
New +$25.2K ﹤0.01% 1759
2021
Q2 		– Sell
-1,000
Closed -$89K – 2419
2021
Q1 		$89K Buy
+1,000
New +$99.2K ﹤0.01% 1183

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Fifth Third Bancorp's ARKG Position: Q2 2026 in Review

Fifth Third Bancorp increased its ARK Genomic Revolution ETF (ARKG) stake by 81% in Q2 2026, buying an estimated $54K and bringing the position to 3,794 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Fifth Third Bancorp first reported a position in ARKG in Q1 2021 and has held it in 5 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Fifth Third Bancorp held 3,794 shares of ARK Genomic Revolution ETF worth $160K as of Q2 2026.
  • Fifth Third Bancorp bought 1,695 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $54K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2727 holding.
  • Fifth Third Bancorp first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 5 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.